Aratana Therapeutics (PETX) Tops Q3 EPS by 10c

November 3, 2016 5:02 PM EDT
Get Alerts PETX Hot Sheet
Trade PETX Now!
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Aratana Therapeutics (NASDAQ: PETX) reported Q3 EPS of ($0.38), $0.10 better than the analyst estimate of ($0.48). Revenue for the quarter came in at $40 thousand versus the consensus estimate of $80 thousand.

For earnings history and earnings-related data on Aratana Therapeutics (PETX) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment